Sevmed 800 Tablet contains Sevelamer, a type of medicine known as Phosphate Binding Agents. It is specifically designed to regulate the phosphorous levels in the blood of patients with chronic kidney disease who are undergoing dialysis treatment. These individuals often experience high levels of phosphorous due to the reduced ability of the kidneys to filter phosphate efficiently, leading to an accumulation in the bloodstream.

To ensure the effectiveness of Sevmed 800 Tablet, your doctor may request certain tests during the course of treatment to monitor any potential adverse effects. It is crucial to adhere to the dietary recommendations provided by your healthcare provider for optimal results.

It is important to note that Sevmed 800 Tablet is not suitable for individuals with low blood phosphorus levels or bowel obstruction. Caution should also be exercised in patients with swallowing difficulties, stomach or bowel motility issues, and those who have undergone significant bowel surgery.

For pregnant women, the use of Sevmed 800 Tablet should only be considered if deemed absolutely necessary by a healthcare professional. It is not known whether the medication is excreted in breast milk and could potentially impact a nursing baby, so consultation with a doctor is recommended before taking Sevmed 800 Tablet while breastfeeding. Additionally, this medication is not intended for use in children and adolescents under the age of 18.

Common side effects associated with Sevmed 800 Tablet include constipation, vomiting, upper abdominal pain, nausea, diarrhea, indigestion, and flatulence. If any of these side effects persist or worsen, it is advisable to seek guidance from your healthcare provider for appropriate management.